BackAnika Therapeutics Overview
Anika Therapeutics Inc.

Anika Therapeutics Target Price

Where could ANIK trade next? Consensus target price: $21.

Get informed when a big investor buys or sells

+ Follow

Share Price

$20.86

Average Target Price

$21.000.7% upside

1 analysts in the last 4 months

High: $21 | Low: $21

Analyst Recommendations

No recommendations in the last 4 months.

Revenue & Income Forecast

Analysts' Target Prices

DateAnalystPrice TargetCurrent Upside/Downside
2026-07-30Barrington$210.7% upsideOpen

Anika Therapeutics (ANIK) FAQ

Anika Therapeutics (ANIK) currently reports a target price of $21. Use the charts on this page to explore Anika Therapeutics's target price history and peer comparisons.

Analysts' average 12-month price target for Anika Therapeutics is $21, about 0.7% upside from the current share price of $20.86. That spread summarizes where covering analysts expect the stock could trade over the next year, not a guarantee. Review the individual firm targets on this page — a wide high-to-low range often means opinion is split.

Start with the current target price of $21, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Anika Therapeutics, and consider following ANIK for alerts when major investors trade the stock.

Anika Therapeutics is classified in the Healthcare sector. On target price, it currently shows $21. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing ANIK with unrelated industries.